GlassScriptPhysician profile
Christopher A Paskowski
NPI 1346298585
$3,321.29
in general payments reported to CMS, 2019-2025
22 companies · $1,122 in 2025
The $1,122 reported for 2025 was more than what 82% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2020: $149 · 2021: $144 · 2022: $247 · 2023: $782 · 2024: $541 · 2025: $1,122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,444.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $937.89 | 2021-2025 | Dupixent |
| Genzyme Corporation | $629.47 | 2019-2025 | |
| Medtronic, INC. | $338.23 | 2022-2025 | Propel, Stealthstation S8 Platform |
| Inspire Medical Systems, INC. | $240.91 | 2023-2025 | Inspire |
| Integra Lifesciences Corporation | $193.01 | 2025 | Relieva Spinplus Nav, Inspira Air, Acclarent Aera |
| Intersect Ent, INC. | $173.08 | 2019-2020 | |
| Glaxosmithkline, LLC. | $118.09 | 2023-2025 | Nucala |
| Paratek Pharmaceuticals, INC. | $115.76 | 2025 | Nuzyra |
| Optinose US, INC. | $111.95 | 2019-2025 | |
| Medtronic USA, INC. | $106.61 | 2020 | |
| Stryker Corporation | $78.96 | 2019-2022 | |
| Hikma Pharmaceuticals USA | $47.27 | 2023-2025 | Ryaltris |
| Sanofi-Aventis U.S. LLC | $43.14 | 2021 | |
| Kaleo, INC. | $41.72 | 2020-2022 | |
| Fortovia Therapeutics, INC. | $29.56 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $22.65 | 2025 | Tezspire |
| Acclarent, INC | $22.06 | 2019 | |
| Cook Medical LLC | $19.11 | 2023 | Biodesign |
| Alk-Abello, INC | $16.43 | 2023 | Grastek, Odactra, Ragwitek |
| Arbor Pharmaceuticals, INC. | $12.15 | 2019 | |
| Novartis Pharmaceuticals Corporation | $11.95 | 2019 | |
| Merck Sharp & Dohme LLC | $11.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Paskowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.